OPRM1 and Alzheimer disease: It may be that our result in AD represents the impact of a confounding variable which affects both endogenous opioid and striatal dopaminergic signalling in AD participants, for example the toxic effect of chronic heavy alcohol use, rather than the modulation of win > neutral anticipation BOLD contrast by MOR signalling in this group.